BCI Affects and Survivorship

Susan K. Boolbol, MD

Video Categories: PMO Interview with the Innovator Series: Volume 8

Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.
January 13, 2015

Benefits of Breast Cancer Index

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.

January 20, 2016

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.